- ►annals.org [PDF] SK Swan, DW Rudy, KC Lasseter, CF Ryan, KL … - Annals of internal medicine, 2000 - Am Coll Physicians Suzanne K. Swan, MD; David W. Rudy, MD; Kenneth C. Lasseter, MD; Charles F.
Ryan, PhD; Kristin L. Buechel, PA-C; Laurence J. Lambrecht, PharmD; Manuel B.
Pinto, BE; Stacy C. Dilzer, RN; Olga Obrda, BS; Kimberly J. Sundblad, BSN; ... Cited by 299 - Related articles - BL Direct - All 6 versions
J Rossat, M Maillard, J Nussberger, HR … - Clinical Pharmacology & Therapeutics, 1999 - nature.com Results: Celecoxib had no effect on systemic blood pressure, but short-term
transient decreases in renal blood flow and glomerular filtration rate were
found with the highest dose of 400 mg on day 1. On the first day, both ... Cited by 264 - Related articles - BL Direct - All 4 versions
A Whelton, G Schulman, C Wallemark, EJ … - Archives of Internal Medicine, 2000 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 212 - Related articles - BL Direct - All 4 versions
- ►aspetjournals.org F Catella-Lawson, B McAdam, BW Morrison, S … - Journal of Pharmacology and Experimental …, 1999 - ASPET Conventional nonsteroidal anti-inflammatory drugs inhibit both cyclooxygenase
(Cox) isoforms (Cox-1 and Cox-2) and may be associated with nephrotoxicity. The
present study was undertaken to assess the renal effects of the specific ... Cited by 483 - Related articles - BL Direct - All 6 versions
MA Perazella, J Eras - American Journal of Kidney Diseases, 2000 - Elsevier Nonsteroidal anti-inflammatory drugs are well-known culprits in the development
of acute renal insufficiency in high-risk patients. The recent release of the
selective cyclooxygenase-2 enzyme inhibitors for the treatment of ... Cited by 143 - Related articles - All 9 versions
A Whelton, CJ Maurath, KM Verburg, GS Geis - American journal of therapeutics, 2000 - journals.lww.com : The novel cyclooxygenase-(COX)-2 inhibitor celecoxib is an effective treatment
for the signs and symptoms of osteoarthritis and rheumatoid arthritis.
Conventional treatment for these debilitating conditions routinely involves ... Cited by 141 - Related articles - BL Direct - All 2 versions
DC Brater - The American journal of medicine, 1999 - Elsevier Nonsteroidal anti-inflammatory drugs (NSAIDs) can affect renal function in a
variety of ways. The most important clinical effects are decreased sodium
excretion, decreased potassium excretion, and declines in renal perfusion. ... Cited by 194 - Related articles - BL Direct - All 6 versions
- ►ajmc.com [PDF] A Whelton, JG Fort, JA Puma, D Normandin, … - American journal of therapeutics, 2001 - journals.lww.com Andrew Whelton,1 John G. Fort,2* Joseph A. Puma,3 Diane Normandin,4 Alfonso E.
Bello,2 and Kenneth M. Verburg,2 for the SUCCESS VI Study Group5 ...
Background: Arthritis and hypertension are common comorbid conditions ... Cited by 261 - Related articles - BL Direct - All 7 versions
F Nantel, E Meadows, D Denis, B Connolly, KM … - FEBS letters, 1999 - Elsevier To gain insight into the role of prostanoids in human kidney function, we
examined the distribution of cyclooxygenase (COX) 1 and COX-2 by
immunofluorescence and immunohistochemistry in human kidneys from adults of ... Cited by 118 - Related articles - All 6 versions
JE Pope, JJ Anderson, DT Felson - Archives of Internal Medicine, 1993 - archinte.highwire.org Methods: A literature search of published English-lan- guage studies of NSAIDs
and theireffects on blood pres- sure was done. Studies were included if they met
the fol- lowing criteria: (1) the studies were intervention studies; (2) ... Cited by 362 - Related articles - BL Direct - All 6 versions
